NBC Securities Inc. Makes New Investment in Chemed Co. (NYSE:CHE)

NBC Securities Inc. acquired a new position in shares of Chemed Co. (NYSE:CHE - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 834 shares of the company's stock, valued at approximately $513,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Somerset Trust Co increased its stake in Chemed by 30.5% during the 1st quarter. Somerset Trust Co now owns 702 shares of the company's stock worth $432,000 after acquiring an additional 164 shares during the period. GAMMA Investing LLC increased its stake in Chemed by 131,200.8% during the 1st quarter. GAMMA Investing LLC now owns 166,752 shares of the company's stock worth $102,606,000 after acquiring an additional 166,625 shares during the period. Versant Capital Management Inc increased its stake in shares of Chemed by 600.0% in the 1st quarter. Versant Capital Management Inc now owns 98 shares of the company's stock valued at $60,000 after purchasing an additional 84 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Chemed by 17.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 1,382 shares of the company's stock valued at $732,000 after purchasing an additional 207 shares during the last quarter. Finally, Centaurus Financial Inc. increased its stake in shares of Chemed by 5.6% in the 4th quarter. Centaurus Financial Inc. now owns 5,354 shares of the company's stock valued at $2,837,000 after purchasing an additional 283 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Chemed Stock Up 0.2%

Shares of CHE traded up $1.06 during midday trading on Friday, hitting $561.84. The company's stock had a trading volume of 79,703 shares, compared to its average volume of 103,174. The stock has a market capitalization of $8.22 billion, a price-to-earnings ratio of 28.39, a price-to-earnings-growth ratio of 2.15 and a beta of 0.54. Chemed Co. has a one year low of $512.12 and a one year high of $623.61. The company's fifty day simple moving average is $575.83 and its two-hundred day simple moving average is $566.08.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. Chemed's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.20 EPS. On average, research analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's dividend payout ratio is 9.74%.

Analyst Ratings Changes

Several brokerages have recently issued reports on CHE. Royal Bank of Canada lifted their price target on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the business's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the completion of the sale, the chief executive officer now directly owns 101,197 shares of the company's stock, valued at approximately $58,335,010.65. The trade was a 1.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have sold 5,500 shares of company stock valued at $3,213,780 in the last ninety days. 3.29% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.